Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Long Term Debt Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual long term debt in 2023 was 5.71 Million PLN , down -22.71% from previous year.
Celon Pharma S.A.'s latest quarterly long term debt in 2024 Q2 was 7.69 Million PLN , down 0.0% from previous quarter.
Celon Pharma S.A. reported annual long term debt of 7.38 Million PLN in 2022, down -11.56% from previous year.
Celon Pharma S.A. reported annual long term debt of 8.35 Million PLN in 2021, up 13.91% from previous year.
Celon Pharma S.A. reported quarterly long term debt of 6.04 Million PLN for 2024 Q1, down 0.0% from previous quarter.
Celon Pharma S.A. reported quarterly long term debt of 5.64 Million PLN for 2023 Q3, down -12.38% from previous quarter.

Annual Long Term Debt Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Long Term Debt of Celon Pharma S.A. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	5.71 Million PLN	-22.71%
2022	7.38 Million PLN	-11.56%
2021	8.35 Million PLN	13.91%
2020	7.33 Million PLN	3680.41%
2019	194 Thousand PLN	0.0%
2018	- PLN	-100.0%
2017	1.7 Million PLN	-43.82%
2016	3.03 Million PLN	-17.3%
2015	3.67 Million PLN	147.46%
2014	1.48 Million PLN	-32.47%
2013	2.19 Million PLN	0.0%
2012	- PLN	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	7.69 Million PLN	0.0%
2024 Q1	6.04 Million PLN	0.0%
2023 Q3	5.64 Million PLN	-12.38%
2023 Q1	8.48 Million PLN	14.85%
2023 Q4	5.71 Million PLN	1.08%
2023 FY	5.71 Million PLN	-22.71%
2023 Q2	6.44 Million PLN	-24.02%
2022 Q2	8.45 Million PLN	-17.37%
2022 FY	7.38 Million PLN	-11.56%
2022 Q4	7.38 Million PLN	-30.38%
2022 Q1	10.23 Million PLN	22.49%
2022 Q3	10.61 Million PLN	25.5%
2021 Q2	8.66 Million PLN	-7.84%
2021 Q4	8.35 Million PLN	-4.02%
2021 Q3	8.7 Million PLN	0.47%
2021 Q1	9.4 Million PLN	28.17%
2021 FY	8.35 Million PLN	13.91%
2020 FY	7.33 Million PLN	3680.41%
2020 Q4	7.33 Million PLN	0.0%
2020 Q3	- PLN	0.0%
2020 Q2	- PLN	0.0%
2020 Q1	- PLN	-100.0%
2019 Q1	988.38 Thousand PLN	0.0%
2019 FY	194 Thousand PLN	0.0%
2019 Q4	194 Thousand PLN	-45.35%
2019 Q3	354.95 Thousand PLN	-33.27%
2019 Q2	531.92 Thousand PLN	-46.18%
2018 FY	- PLN	-100.0%
2018 Q2	1.22 Million PLN	-58.26%
2018 Q3	976.84 Thousand PLN	-20.51%
2018 Q1	2.94 Million PLN	72.44%
2018 Q4	- PLN	-100.0%
2017 Q1	5.42 Million PLN	78.42%
2017 Q2	1.18 Million PLN	-78.09%
2017 Q3	879.66 Thousand PLN	-25.95%
2017 Q4	1.7 Million PLN	94.07%
2017 FY	1.7 Million PLN	-43.82%
2016 FY	3.03 Million PLN	-17.3%
2016 Q4	3.03 Million PLN	-51.64%
2016 Q1	- PLN	-100.0%
2016 Q3	6.28 Million PLN	0.0%
2015 Q4	3.67 Million PLN	0.0%
2015 FY	3.67 Million PLN	147.46%
2014 FY	1.48 Million PLN	-32.47%
2013 FY	2.19 Million PLN	0.0%
2012 FY	- PLN	0.0%

Peer Long Term Debt Comparison of Celon Pharma S.A.

Name	Long Term Debt	Long Term Debt Difference